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ABSTRACT RESEARCH & RESULTS
In recent years, nanocarrier cellular therapy has been a rapidly 
growing area for research in the treatment of malignant and 
infectious diseases – most notably cancer. Conventional cancer 
treatment has consisted of highly toxic, highly insoluble, 
untargeted delivery of drugs that kill both cancerous and 
healthy cells. Research in the Tomich lab consists of the 
synthesis of Branched Amphiphilic Peptide Capsules (BAPCs), 
which are self-assembling peptide nanospheres composed of 
one or both of these branched peptide sequences: h5 and h9. 
These peptides possess similar molecular characteristics of 
phosphoglycerides but are synthesized chemically within the 
lab. Previous publications by the Tomich group have 
demonstrated that BAPCs are stabilized by hydrophobic 
interactions and hydrogen bonds. Here, we further explore the 
ability of BAPCs to retain their nanosphere shape and 
encapsulated solutes at varying DMSO (dimethyl-sulfoxide) 
concentrations (0%, 10%, and 25%) and pH (3.5, 7.5, 8.5) levels. 
Using this framework, we will attach a short peptide to the 
outside of the BAPCs using reversible disulfide linkages. This 
coupling will be followed using Ellman’s reagent as a 
quantitative measurement for reduced versus oxidized cysteines 
and MALDI-TOF mass spectrometry. Data presented here will 
show which conditions most favorably contribute to the 
disulfide formation between the BAPC and the peptide in the 
presence of DMSO. Upon cellular uptake, the reducing 
environment of the cell’s interior will release the peptide. With 
the changing face of diseases and medicine, the ability to attach 
and encapsulate molecules of interest onto and within BAPCs 
opens the door to many other therapeutic possibilities. This 
suggests that BAPCs can be an attractive biocompatible carrier 
for the delivery of various cancer therapy drugs.
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The first experimental procedure, regarding BAPCs containing the dye Eosin (2.1mM), was observed over a set temperature  
where no fluorescence discrepancies were observed. Concluding that these BAPCS did not rapture and release the Eosin dye.
Knowing that BAPCS could retain Eosin, we then decided to run Eosin encapsulated BAPCS under 0%, 10%, and 25% DMSO – for 
all pH values of 3.5, 7.5, and 8.5 respectively. Again, we were able to demonstrate that the BAPC was able to retain its shape 
even at 25% DMSO. Graph 2 and 3 describe the H9-Cys peptide and Fleming peptide, both under DMSO condition and Ellmans
reagent. Here we are able to see how the Ellmans reagent affects the disulfide bonds and interacts with our peptide. Lastly, 
from data collected on the MALDI-TOF we were able to detect noticeable differences not just from pH, but from DMSO variation 
at our peak of interest ~3788. 
DISCUSSION/INTERPRETATION
- Peptides were synthesized in lab by solid phase Fmoc
chemistry with clear amide being the starting resin.
- Concentrations were determined 
by dissolving in 2,2,2-
trifluoroethanol and running 
through the Varian 50 Bio UV-
Spectrophotometer (accounting for 
phenylalanine).
- The CARY Eclipse fluorescence 
spectrophotometer was used to 
measure fluorescence. Beginning 
with a 500 nm excitation 
wavelength, followed by the 
observation from 505 to 698nm 
using a 0.3 cm quartz cuvette.
- During the hydration of the BAPCs, 1mM of each peptide was 
combined and Eosin Y was added in a drop-wise manner. 
- After hydrating for ~45 minutes, each solution was filtered 
and centrifuged at 14,000 x g, in a  weight cut off Eppendorf 
filter of 30kDa to removed any external dyes. 
- Filters were inverted and centrifuged at 2,000 x g, to collect 
the BAPCs.
- The use of the Varian 50 Bio, was used for multiple scans.
- Samples were ran again under no Elllmans reagent and were 
spotted under MALDI-TOF.
- Peaks of interest where further analyzed via mass 
spectrometry and graphed.
BAPCs have demonstrated great 
stability while having fine tune-
availability. These amphipathic particles 
self assemble and form a functional 
membrane like bilayer; Fig. 2, 3 –
composed of a hydrophobic outer 
membrane and a hydrophilic inner 
membrane. Their formation occurs 
when two (15-20 residue) poly-cationic 
peptides are mixed. Fig. 1 shows the 
chemical structure of three usable 
peptides. The ‘blue’ labeled lysine on all 
represents a 90° segment common in 
diacyl phospholipid. 
Graph 2: H9-cysteine and Ellmans reagent under varying DMSO 
concentrations.
Fig. 2 Midsection BAPCs
Fig. 3 BAPC micelle
Our data reveled that a more basic solution is preferred in order 
for reduction to take place. This being the case, future studies 
would consist of testing different ions and their affects on BAPCs 
stability. Other future work includes the identification of certain 
unknown peaks in the MALDI-TOF analysis, as some adducts 
would appear; such as sodium and potassium. Recognizing the 
ability of water to permeate through the bilayer has also given 
rise to other possible applications – such as water filtration in 
developing countries, to the possible improvement of current 
reverse osmosis techniques. The most important future plan, 
however, is to successfully modify this delivery vehicle in order 
to begin clinal trials. 
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Graph 1: Details Eosin-BAPCS encapsulation and fluoresce. 
Graph 4 and 5: Show 
data from the MALDI-
TOF mass spectrometry, 
peaks of interest are 
emphasized by being 
boxed. Here, graph 4 
shows that an 




presented on these 
graphs did not include 
the addition of Ellmans
reagent. Graph 4 Graph 5
Graph 2 and 3: Demonstrates three 
different constituents which make the 
graph. First, the initial points on the graph 
belong to the blank absorbances at 412nm 
for all our samples collected.
The next set of data points emphasize the 
absorbance of our Ellmans reagent with 
only pH buffer conditions (3.5,7.5,8.5).
Lastly, beginning at x=0, the peptides (H9-
Cys and Fleming) are introduced to the 
Ellmans and pH buffer at varying 
concentrations of DMSO at time intervals 
of 1hour for 13 cycles. Graph 3
